- New Data from MAVORIC Trial Sheds Light on Key Characteristics of Long-term POTELIGEO® (mogamulizumab-kpkc) Responders with Specific Subtypes of Cutaneous T-cell Lymphoma
- Ardelyx and Kyowa Kirin Highlight New Data Supporting the Clinical Safety and Efficacy of First-In-Class, Phosphate Absorption Inhibitor Tenapanor at ASN's Kidney Week 2020
- Kyowa Kirin North America Announces Recipients of Patient Education Grants to Address Disparities for African-American Patients with Cutaneous T-Cell Lymphomas (CTCL)
Key statistics
On Friday, Kyowa Kirin Co Ltd (4151:TYO) closed at 2,818.00, -7.91% below its 52-week high of 3,060.00, set on Sep 30, 2020.
52-week range
Markit short selling activity
Open | 2,788.00 |
---|---|
High | 2,834.00 |
Low | 2,788.00 |
Bid | 2,816.00 |
Offer | 2,819.00 |
Previous close | 2,789.00 |
Average volume | 659.46k |
---|---|
Shares outstanding | 540.00m |
Free float | 249.90m |
P/E (TTM) | 31.39 |
Market cap | 1.52tn JPY |
EPS (TTM) | 89.78 JPY |
Annual div (ADY) | 44.00 JPY |
---|---|
Annual div yield (ADY) | 1.56% |
Div ex-date | Dec 29 2020 |
Div pay-date | -- |
Data delayed at least 20 minutes, as of Jan 15 2021 06:00 GMT.
More ▼